APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Omics Data Analysis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Omics Data Analysis Service Market Analysis and Forecast 2026-2032

16 April 2026251 pages

Choose your research edition.

Industry ResearchOmics Data Analysis Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Omics Data Analysis Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Omics Data Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omics Data Analysis Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Omics Data Analysis Service Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global Omics Data Analysis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Omics Data Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Omics Data Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Omics Data Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Omics Data Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Omics Data Analysis Service include Acobiom, AltraBio, BGI Genomics, Biogenity, Tempus, Cmbio, Creative Proteomics, Firalis Molecular Precision and Metware Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Omics Data Analysis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Omics Data Analysis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Omics Data Analysis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Omics Data Analysis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Omics Data Analysis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Omics Data Analysis Service revenue, projected growth trends, production technology, application and end-user industry.

Omics Data Analysis Service Segment by Company

Acobiom

AltraBio

BGI Genomics

Biogenity

Tempus

Cmbio

Creative Proteomics

Firalis Molecular Precision

Metware Biotechnology

Nuvisan

Omics Data Solutions

PharmaLex

Standard BioTools

PIPA AI

Seven Bridges

Omics Data Analysis Service Segment by Type

Genomic Analysis

Transcriptomic Analysis

Proteomic Analysis

Metabolomic Analysis

Epigenomic Analysis

Microbiome Analysis

Others

Omics Data Analysis Service Segment by Application

Developmental Biology

Clinical Medicine

Precision Diagnosis

Drug Development

Others

Omics Data Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omics Data Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omics Data Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omics Data Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Omics Data Analysis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Omics Data Analysis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Omics Data Analysis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Omics Data Analysis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Genomic Analysis Major Player Table 3. Transcriptomic Analysis Major Player Table 4. Proteomic Analysis Major Player Table 5. Metabolomic Analysis Major Player Table 6. Epigenomic Analysis Major Player Table 7. Microbiome Analysis Major Player Table 8. Others Major Player Table 9. Global Omics Data Analysis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Developmental Biology Major Player Table 11. Clinical Medicine Major Player Table 12. Precision Diagnosis Major Player Table 13. Drug Development Major Player Table 14. Others Major Player Table 15. Omics Data Analysis Service Industry Trends Table 16. Omics Data Analysis Service Industry Drivers Table 17. Omics Data Analysis Service Industry Opportunities and Challenges Table 18. Omics Data Analysis Service Industry Restraints Table 19. Global Omics Data Analysis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Omics Data Analysis Service Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Omics Data Analysis Service Market Share by Region (2021-2026) Table 22. Global Omics Data Analysis Service Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Omics Data Analysis Service Market Share by Region (2027-2032) Table 24. Global Omics Data Analysis Service Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Omics Data Analysis Service Revenue Market Share by Players (2021-2026) Table 26. Global Omics Data Analysis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Omics Data Analysis Service Key Players Headquarters & Area Served Table 28. Global Omics Data Analysis Service Players, Product Type & Application Table 29. Global Omics Data Analysis Service Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Omics Data Analysis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Omics Data Analysis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Omics Data Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Omics Data Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Omics Data Analysis Service Revenue Market Share by Type (2021-2026) Table 36. Global Omics Data Analysis Service Revenue Market Share by Type (2027-2032) Table 37. Global Omics Data Analysis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Omics Data Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Omics Data Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Omics Data Analysis Service Revenue Market Share by Application (2021-2026) Table 41. Global Omics Data Analysis Service Revenue Market Share by Application (2027-2032) Table 42. Acobiom Company Information Table 43. Acobiom Business Overview Table 44. Acobiom Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Acobiom Omics Data Analysis Service Product Portfolio Table 46. Acobiom Recent Development Table 47. AltraBio Company Information Table 48. AltraBio Business Overview Table 49. AltraBio Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. AltraBio Omics Data Analysis Service Product Portfolio Table 51. AltraBio Recent Development Table 52. BGI Genomics Company Information Table 53. BGI Genomics Business Overview Table 54. BGI Genomics Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. BGI Genomics Omics Data Analysis Service Product Portfolio Table 56. BGI Genomics Recent Development Table 57. Biogenity Company Information Table 58. Biogenity Business Overview Table 59. Biogenity Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Biogenity Omics Data Analysis Service Product Portfolio Table 61. Biogenity Recent Development Table 62. Tempus Company Information Table 63. Tempus Business Overview Table 64. Tempus Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Tempus Omics Data Analysis Service Product Portfolio Table 66. Tempus Recent Development Table 67. Cmbio Company Information Table 68. Cmbio Business Overview Table 69. Cmbio Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cmbio Omics Data Analysis Service Product Portfolio Table 71. Cmbio Recent Development Table 72. Creative Proteomics Company Information Table 73. Creative Proteomics Business Overview Table 74. Creative Proteomics Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Creative Proteomics Omics Data Analysis Service Product Portfolio Table 76. Creative Proteomics Recent Development Table 77. Firalis Molecular Precision Company Information Table 78. Firalis Molecular Precision Business Overview Table 79. Firalis Molecular Precision Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Firalis Molecular Precision Omics Data Analysis Service Product Portfolio Table 81. Firalis Molecular Precision Recent Development Table 82. Metware Biotechnology Company Information Table 83. Metware Biotechnology Business Overview Table 84. Metware Biotechnology Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Metware Biotechnology Omics Data Analysis Service Product Portfolio Table 86. Metware Biotechnology Recent Development Table 87. Nuvisan Company Information Table 88. Nuvisan Business Overview Table 89. Nuvisan Omics Data Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Nuvisan Omics Data Analysis Service Product Portfolio Table 91. Nuvisan Recent Development Table 92. Omics Data Solutions Company Information Table 93. Omics Data Solutions Business Overview Table 94. Omics Data Solutions Omics Data Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Omics Data Solutions Omics Data Analysis Service Product Portfolio Table 96. Omics Data Solutions Recent Development Table 97. PharmaLex Company Information Table 98. PharmaLex Business Overview Table 99. PharmaLex Omics Data Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. PharmaLex Omics Data Analysis Service Product Portfolio Table 101. PharmaLex Recent Development Table 102. Standard BioTools Company Information Table 103. Standard BioTools Business Overview Table 104. Standard BioTools Omics Data Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Standard BioTools Omics Data Analysis Service Product Portfolio Table 106. Standard BioTools Recent Development Table 107. PIPA AI Company Information Table 108. PIPA AI Business Overview Table 109. PIPA AI Omics Data Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. PIPA AI Omics Data Analysis Service Product Portfolio Table 111. PIPA AI Recent Development Table 112. Seven Bridges Company Information Table 113. Seven Bridges Business Overview Table 114. Seven Bridges Omics Data Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Seven Bridges Omics Data Analysis Service Product Portfolio Table 116. Seven Bridges Recent Development Table 117. North America Omics Data Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Omics Data Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Omics Data Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Omics Data Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Omics Data Analysis Service Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Omics Data Analysis Service Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Omics Data Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Omics Data Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Omics Data Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Omics Data Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Omics Data Analysis Service Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Omics Data Analysis Service Revenue by Country (US$ Million) & (2027-2032) Table 131. China Omics Data Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 132. China Omics Data Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 133. China Omics Data Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 134. China Omics Data Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Omics Data Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Omics Data Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Omics Data Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Omics Data Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Omics Data Analysis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Omics Data Analysis Service Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Omics Data Analysis Service Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Omics Data Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Omics Data Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Omics Data Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Omics Data Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Omics Data Analysis Service Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Omics Data Analysis Service Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Omics Data Analysis Service Image Figure 2. Global Omics Data Analysis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omics Data Analysis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Genomic Analysis Image Figure 5. Transcriptomic Analysis Image Figure 6. Proteomic Analysis Image Figure 7. Metabolomic Analysis Image Figure 8. Epigenomic Analysis Image Figure 9. Microbiome Analysis Image Figure 10. Others Image Figure 11. Global Omics Data Analysis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Omics Data Analysis Service Market Size Share 2021 VS 2025 VS 2032 Figure 13. Developmental Biology Image Figure 14. Clinical Medicine Image Figure 15. Precision Diagnosis Image Figure 16. Drug Development Image Figure 17. Others Image Figure 18. Global Omics Data Analysis Service Market Size (US$ Million) & (2021-2032) Figure 19. Global Omics Data Analysis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Omics Data Analysis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Omics Data Analysis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Omics Data Analysis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Omics Data Analysis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Omics Data Analysis Service Revenue Market Share by Type (2021-2032) Figure 26. Global Omics Data Analysis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Omics Data Analysis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Omics Data Analysis Service Revenue Market Share by Application (2021-2032) Figure 29. North America Omics Data Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Omics Data Analysis Service Revenue Share by Type (2021-2032) Figure 31. North America Omics Data Analysis Service Revenue Share by Application (2021-2032) Figure 32. North America Omics Data Analysis Service Revenue Share by Country (2021-2032) Figure 33. United States Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Omics Data Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Omics Data Analysis Service Revenue Share by Type (2021-2032) Figure 38. Europe Omics Data Analysis Service Revenue Share by Application (2021-2032) Figure 39. Europe Omics Data Analysis Service Revenue Share by Country (2021-2032) Figure 40. Germany Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Omics Data Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Omics Data Analysis Service Revenue Share by Type (2021-2032) Figure 50. China Omics Data Analysis Service Revenue Share by Application (2021-2032) Figure 51. Asia Omics Data Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Omics Data Analysis Service Revenue Share by Type (2021-2032) Figure 53. Asia Omics Data Analysis Service Revenue Share by Application (2021-2032) Figure 54. Asia Omics Data Analysis Service Revenue Share by Region (2021-2032) Figure 55. Japan Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Omics Data Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Omics Data Analysis Service Revenue Share by Type (2021-2032) Figure 63. SAMEA Omics Data Analysis Service Revenue Share by Application (2021-2032) Figure 64. SAMEA Omics Data Analysis Service Revenue Share by Country (2021-2032) Figure 65. Brazil Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Omics Data Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Genomic Analysis
  • Transcriptomic Analysis
  • Proteomic Analysis
  • Metabolomic Analysis
  • Epigenomic Analysis
  • Microbiome Analysis
  • Others
Applications
  • Developmental Biology
  • Clinical Medicine
  • Precision Diagnosis
  • Drug Development
  • Others
Companies covered
  • Acobiom
  • AltraBio
  • BGI Genomics
  • Biogenity
  • Tempus
  • Cmbio
  • Creative Proteomics
  • Firalis Molecular Precision
  • Metware Biotechnology
  • Nuvisan
  • Omics Data Solutions
  • PharmaLex
  • Standard BioTools
  • PIPA AI
  • Seven Bridges

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Omics Data Analysis Service Market by Type
  3. 1.2.1 Global Omics Data Analysis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Genomic Analysis
  5. 1.2.3 Transcriptomic Analysis
  6. 1.2.4 Proteomic Analysis
  7. 1.2.5 Metabolomic Analysis
  8. 1.2.6 Epigenomic Analysis
  9. 1.2.7 Microbiome Analysis
  10. 1.2.8 Others
  11. 1.3 Omics Data Analysis Service Market by Application
  12. 1.3.1 Global Omics Data Analysis Service Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Developmental Biology
  14. 1.3.3 Clinical Medicine
  15. 1.3.4 Precision Diagnosis
  16. 1.3.5 Drug Development
  17. 1.3.6 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Omics Data Analysis Service Market Dynamics
  1. 2.1 Omics Data Analysis Service Industry Trends
  2. 2.2 Omics Data Analysis Service Industry Drivers
  3. 2.3 Omics Data Analysis Service Industry Opportunities and Challenges
  4. 2.4 Omics Data Analysis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Omics Data Analysis Service Market Perspective (2021-2032)
  2. 3.2 Global Omics Data Analysis Service Growth Trends by Region
  3. 3.2.1 Global Omics Data Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Omics Data Analysis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Omics Data Analysis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Omics Data Analysis Service Revenue by Players
  2. 4.1.1 Global Omics Data Analysis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Omics Data Analysis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Omics Data Analysis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Omics Data Analysis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Omics Data Analysis Service Key Players Headquarters & Area Served
  7. 4.4 Global Omics Data Analysis Service Players, Product Type & Application
  8. 4.5 Global Omics Data Analysis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Omics Data Analysis Service Market CR5 and HHI
  11. 4.6.3 2025 Omics Data Analysis Service Tier 1, Tier 2, and Tier 3
5 Omics Data Analysis Service Market Size by Type
  1. 5.1 Global Omics Data Analysis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Omics Data Analysis Service Revenue by Type (2021-2032)
  3. 5.3 Global Omics Data Analysis Service Revenue Market Share by Type (2021-2032)
6 Omics Data Analysis Service Market Size by Application
  1. 6.1 Global Omics Data Analysis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Omics Data Analysis Service Revenue by Application (2021-2032)
  3. 6.3 Global Omics Data Analysis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Acobiom
  2. 7.1.1 Acobiom Company Information
  3. 7.1.2 Acobiom Business Overview
  4. 7.1.3 Acobiom Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Acobiom Omics Data Analysis Service Product Portfolio
  6. 7.1.5 Acobiom Recent Developments
  7. 7.2 AltraBio
  8. 7.2.1 AltraBio Company Information
  9. 7.2.2 AltraBio Business Overview
  10. 7.2.3 AltraBio Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AltraBio Omics Data Analysis Service Product Portfolio
  12. 7.2.5 AltraBio Recent Developments
  13. 7.3 BGI Genomics
  14. 7.3.1 BGI Genomics Company Information
  15. 7.3.2 BGI Genomics Business Overview
  16. 7.3.3 BGI Genomics Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BGI Genomics Omics Data Analysis Service Product Portfolio
  18. 7.3.5 BGI Genomics Recent Developments
  19. 7.4 Biogenity
  20. 7.4.1 Biogenity Company Information
  21. 7.4.2 Biogenity Business Overview
  22. 7.4.3 Biogenity Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Biogenity Omics Data Analysis Service Product Portfolio
  24. 7.4.5 Biogenity Recent Developments
  25. 7.5 Tempus
  26. 7.5.1 Tempus Company Information
  27. 7.5.2 Tempus Business Overview
  28. 7.5.3 Tempus Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tempus Omics Data Analysis Service Product Portfolio
  30. 7.5.5 Tempus Recent Developments
  31. 7.6 Cmbio
  32. 7.6.1 Cmbio Company Information
  33. 7.6.2 Cmbio Business Overview
  34. 7.6.3 Cmbio Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cmbio Omics Data Analysis Service Product Portfolio
  36. 7.6.5 Cmbio Recent Developments
  37. 7.7 Creative Proteomics
  38. 7.7.1 Creative Proteomics Company Information
  39. 7.7.2 Creative Proteomics Business Overview
  40. 7.7.3 Creative Proteomics Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Proteomics Omics Data Analysis Service Product Portfolio
  42. 7.7.5 Creative Proteomics Recent Developments
  43. 7.8 Firalis Molecular Precision
  44. 7.8.1 Firalis Molecular Precision Company Information
  45. 7.8.2 Firalis Molecular Precision Business Overview
  46. 7.8.3 Firalis Molecular Precision Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Firalis Molecular Precision Omics Data Analysis Service Product Portfolio
  48. 7.8.5 Firalis Molecular Precision Recent Developments
  49. 7.9 Metware Biotechnology
  50. 7.9.1 Metware Biotechnology Company Information
  51. 7.9.2 Metware Biotechnology Business Overview
  52. 7.9.3 Metware Biotechnology Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Metware Biotechnology Omics Data Analysis Service Product Portfolio
  54. 7.9.5 Metware Biotechnology Recent Developments
  55. 7.10 Nuvisan
  56. 7.10.1 Nuvisan Company Information
  57. 7.10.2 Nuvisan Business Overview
  58. 7.10.3 Nuvisan Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Nuvisan Omics Data Analysis Service Product Portfolio
  60. 7.10.5 Nuvisan Recent Developments
  61. 7.11 Omics Data Solutions
  62. 7.11.1 Omics Data Solutions Company Information
  63. 7.11.2 Omics Data Solutions Business Overview
  64. 7.11.3 Omics Data Solutions Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Omics Data Solutions Omics Data Analysis Service Product Portfolio
  66. 7.11.5 Omics Data Solutions Recent Developments
  67. 7.12 PharmaLex
  68. 7.12.1 PharmaLex Company Information
  69. 7.12.2 PharmaLex Business Overview
  70. 7.12.3 PharmaLex Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 PharmaLex Omics Data Analysis Service Product Portfolio
  72. 7.12.5 PharmaLex Recent Developments
  73. 7.13 Standard BioTools
  74. 7.13.1 Standard BioTools Company Information
  75. 7.13.2 Standard BioTools Business Overview
  76. 7.13.3 Standard BioTools Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Standard BioTools Omics Data Analysis Service Product Portfolio
  78. 7.13.5 Standard BioTools Recent Developments
  79. 7.14 PIPA AI
  80. 7.14.1 PIPA AI Company Information
  81. 7.14.2 PIPA AI Business Overview
  82. 7.14.3 PIPA AI Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 PIPA AI Omics Data Analysis Service Product Portfolio
  84. 7.14.5 PIPA AI Recent Developments
  85. 7.15 Seven Bridges
  86. 7.15.1 Seven Bridges Company Information
  87. 7.15.2 Seven Bridges Business Overview
  88. 7.15.3 Seven Bridges Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Seven Bridges Omics Data Analysis Service Product Portfolio
  90. 7.15.5 Seven Bridges Recent Developments
8 North America
  1. 8.1 North America Omics Data Analysis Service Revenue (2021-2032)
  2. 8.2 North America Omics Data Analysis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Omics Data Analysis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Omics Data Analysis Service Revenue by Type (2027-2032)
  5. 8.3 North America Omics Data Analysis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Omics Data Analysis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Omics Data Analysis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Omics Data Analysis Service Revenue by Application (2027-2032)
  9. 8.5 North America Omics Data Analysis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Omics Data Analysis Service Revenue by Country
  11. 8.6.1 North America Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Omics Data Analysis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Omics Data Analysis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Omics Data Analysis Service Revenue (2021-2032)
  2. 9.2 Europe Omics Data Analysis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Omics Data Analysis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Omics Data Analysis Service Revenue by Type (2027-2032)
  5. 9.3 Europe Omics Data Analysis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Omics Data Analysis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Omics Data Analysis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Omics Data Analysis Service Revenue by Application (2027-2032)
  9. 9.5 Europe Omics Data Analysis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Omics Data Analysis Service Revenue by Country
  11. 9.6.1 Europe Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Omics Data Analysis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Omics Data Analysis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Omics Data Analysis Service Revenue (2021-2032)
  2. 10.2 China Omics Data Analysis Service Revenue by Type (2021-2032)
  3. 10.2.1 China Omics Data Analysis Service Revenue by Type (2021-2026)
  4. 10.2.2 China Omics Data Analysis Service Revenue by Type (2027-2032)
  5. 10.3 China Omics Data Analysis Service Revenue Share by Type (2021-2032)
  6. 10.4 China Omics Data Analysis Service Revenue by Application (2021-2032)
  7. 10.4.1 China Omics Data Analysis Service Revenue by Application (2021-2026)
  8. 10.4.2 China Omics Data Analysis Service Revenue by Application (2027-2032)
  9. 10.5 China Omics Data Analysis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Omics Data Analysis Service Revenue (2021-2032)
  2. 11.2 Asia Omics Data Analysis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Omics Data Analysis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Omics Data Analysis Service Revenue by Type (2027-2032)
  5. 11.3 Asia Omics Data Analysis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Omics Data Analysis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Omics Data Analysis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Omics Data Analysis Service Revenue by Application (2027-2032)
  9. 11.5 Asia Omics Data Analysis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Omics Data Analysis Service Revenue by Country
  11. 11.6.1 Asia Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Omics Data Analysis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Omics Data Analysis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Omics Data Analysis Service Revenue (2021-2032)
  2. 12.2 SAMEA Omics Data Analysis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Omics Data Analysis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Omics Data Analysis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Omics Data Analysis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Omics Data Analysis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Omics Data Analysis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Omics Data Analysis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Omics Data Analysis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Omics Data Analysis Service Revenue by Country
  11. 12.6.1 SAMEA Omics Data Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Omics Data Analysis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Omics Data Analysis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst